🚀 VC round data is live in beta, check it out!
Affluent Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Affluent Medical and similar public comparables like Paxman, Zomedica, Apyx Medical, CROSSJECT and more.
Affluent Medical Overview
Founded
N/A
HQ
—
Employees
67
Website
N/A
Financials (LTM)
EV
$151M
Affluent Medical Financials
Affluent Medical reported last 12-month revenue of $570K and negative EBITDA of ($18M).
In the same LTM period, Affluent Medical generated ($18M) in EBITDA losses and had net loss of ($22M).
Revenue (LTM)
Affluent Medical P&L
In the most recent fiscal year, Affluent Medical reported revenue of — and net income of —.
Affluent Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $570K | XXX | — | XXX | XXX | XXX |
| EBITDA | ($18M) | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | (3193%) | XXX | — | XXX | XXX | XXX |
| EBIT Margin | (3782%) | XXX | — | XXX | XXX | XXX |
| Net Profit | ($22M) | XXX | — | XXX | XXX | XXX |
| Net Margin | (3917%) | XXX | — | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Affluent Medical Stock Performance
Affluent Medical has current market cap of $130M, and enterprise value of $151M.
Affluent Medical's stock price is $3.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $151M | $130M | (0.1%) | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAffluent Medical Valuation Multiples
Affluent Medical trades at 264.9x EV/Revenue multiple, and (8.3x) EV/EBITDA.
Affluent Medical Financial Valuation Multiples
As of March 7, 2026, Affluent Medical has market cap of $130M and EV of $151M.
Equity research analysts estimate Affluent Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Affluent Medical has a P/E ratio of (5.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $130M | XXX | $130M | XXX | XXX | XXX |
| EV (current) | $151M | XXX | $151M | XXX | XXX | XXX |
| EV/Revenue | 264.9x | XXX | — | XXX | XXX | XXX |
| EV/EBITDA | (8.3x) | XXX | — | XXX | XXX | XXX |
| EV/EBIT | (7.0x) | XXX | — | XXX | XXX | XXX |
| P/E | (5.8x) | XXX | — | XXX | XXX | XXX |
| EV/FCF | (8.1x) | XXX | — | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Affluent Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Affluent Medical Margins & Growth Rates
Affluent Medical's revenue in the last 12 month grew by 454%.
Affluent Medical's revenue per employee in the last FY averaged $0.0M.
Affluent Medical's rule of 40 is (2739%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Affluent Medical's rule of X is (2057%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Affluent Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 454% | XXX | (87%) | XXX | XXX | XXX |
| EBITDA Margin | (3193%) | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | 38% | XXX | 37% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (2739%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (2057%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Affluent Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Paxman | XXX | XXX | XXX | XXX | XXX | XXX |
| Zomedica | XXX | XXX | XXX | XXX | XXX | XXX |
| Apyx Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| CROSSJECT | XXX | XXX | XXX | XXX | XXX | XXX |
| BICO Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Affluent Medical M&A Activity
Affluent Medical acquired XXX companies to date.
Last acquisition by Affluent Medical was on XXXXXXXX, XXXXX. Affluent Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Affluent Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAffluent Medical Investment Activity
Affluent Medical invested in XXX companies to date.
Affluent Medical made its latest investment on XXXXXXXX, XXXXX. Affluent Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Affluent Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Affluent Medical
| How many employees does Affluent Medical have? | As of today, Affluent Medical has over 67 employees. |
| Is Affluent Medical publicly listed? | Yes, Affluent Medical is a public company listed on Euronext Paris. |
| What is the stock symbol of Affluent Medical? | Affluent Medical trades under AFME ticker. |
| When did Affluent Medical go public? | Affluent Medical went public in 2021. |
| Who are competitors of Affluent Medical? | Affluent Medical main competitors are Paxman, Zomedica, Apyx Medical, CROSSJECT. |
| What is the current market cap of Affluent Medical? | Affluent Medical's current market cap is $130M. |
| What is the current revenue of Affluent Medical? | Affluent Medical's last 12 months revenue is $570K. |
| What is the current revenue growth of Affluent Medical? | Affluent Medical revenue growth (NTM/LTM) is 454%. |
| What is the current EV/Revenue multiple of Affluent Medical? | Current revenue multiple of Affluent Medical is 264.9x. |
| Is Affluent Medical profitable? | No, Affluent Medical is not profitable. |
| What is the current EBITDA of Affluent Medical? | Affluent Medical has negative EBITDA and is not profitable. |
| What is Affluent Medical's EBITDA margin? | Affluent Medical's last 12 months EBITDA margin is (3193%). |
| What is the current EV/EBITDA multiple of Affluent Medical? | Current EBITDA multiple of Affluent Medical is (8.3x). |
| What is the current FCF of Affluent Medical? | Affluent Medical's last 12 months FCF is ($19M). |
| What is Affluent Medical's FCF margin? | Affluent Medical's last 12 months FCF margin is (3286%). |
| What is the current EV/FCF multiple of Affluent Medical? | Current FCF multiple of Affluent Medical is (8.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.